Camlin Fine Sciences Limited (NSE:CAMLINFINE)
121.50
-2.39 (-1.93%)
Jul 22, 2026, 3:30 PM IST
Camlin Fine Sciences Market Cap
Camlin Fine Sciences has a market cap or net worth of 23.35 billion as of July 22, 2026. Its market cap has decreased by -56.87% in one year.
Market Cap
23.35B
Enterprise Value
29.06B
Revenue
17.23B
Ranking
n/a
PE Ratio
84.51
Stock Price
121.50
ChartMarket Cap Chart
Since March 30, 2007, Camlin Fine Sciences's market cap has increased from 412.25M to 23.35B, an increase of 5,563.75%. That is a compound annual growth rate of 23.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 23.35B | -18.06% |
| Dec 31, 2025 | 28.50B | 29.67% |
| Dec 31, 2024 | 21.98B | -3.40% |
| Dec 29, 2023 | 22.75B | -9.51% |
| Dec 30, 2022 | 25.14B | 51.29% |
| Dec 31, 2021 | 16.62B | 6.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savita Oil Technologies | 39.78B |
| Advanced Enzyme Technologies | 35.90B |
| Tatva Chintan Pharma Chem | 33.41B |
| Jubilant Agri and Consumer Products | 30.34B |
| Rossari Biotech | 29.44B |
| NOCIL | 27.17B |
| Stallion India Fluorochemicals | 24.93B |
| Veedol Corporation | 23.94B |